Abivax (ABVX) Goodwill (2021 - 2026)

Abivax's Goodwill history runs 6 years deep, the most recent figure standing at $21.6 million for Q1 2026.

• On a quarterly basis, Goodwill rose 11.3% year-over-year to $21.6 million in Q1 2026; TTM through Mar 2026 was $21.6 million, a 11.3% increase from a year earlier, with the FY2025 full-year figure at $21.4 million, up 7.55% from the prior year.
• Goodwill advanced to $21.6 million in Q1 2026 per ABVX's latest filing, from $21.4 million in the prior quarter.
• Across five years, Goodwill topped out at $21.6 million in Q1 2026 and bottomed at $18.8 million in Q4 2022.
• The 5-year median for Goodwill is $19.8 million (2024), against an average of $20.3 million.
• Across the five-year window, Goodwill tumbled 48.67% in 2022 and climbed 11.3% in 2026, its largest moves.
• Year by year, Goodwill stood at $18.8 million in 2022, then rose by 5.46% to $19.8 million in 2023, then dropped by 0.68% to $19.7 million in 2024, then rose by 8.93% to $21.4 million in 2025, then climbed by 0.58% to $21.6 million in 2026.
• Per Business Quant, the three latest ABVX Goodwill figures stand at $21.6 million (Q1 2026), $21.4 million (Q4 2025), and $21.5 million (Q3 2025).